首页> 外文期刊>Indian drugs >FORMULATION DEVELOPMENT OF MATRIX TABLET OF STAVUDINE BY USING CARBOXY METHYL TAMARIND KERNEL POWDER AS A NOVEL DRUG RELEASE RETARDING AGENT
【24h】

FORMULATION DEVELOPMENT OF MATRIX TABLET OF STAVUDINE BY USING CARBOXY METHYL TAMARIND KERNEL POWDER AS A NOVEL DRUG RELEASE RETARDING AGENT

机译:羧基甲基他玛琳核仁粉末作为新型药物缓释剂的研制成功开发了司他夫定基质片剂

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to evaluate carboxy methyl tamarind kernal powder as a novel drug release retarding agent. To evaluate the same, sustained release matrix tablets of stavudine were prepared by using HPMC K4M and carboxy methyl tamarind kernal powder, by using a direct compression technique. The formulations were prepared by using different drug: polymer ratios into formulations such as F1 to F9. The compressed tablets were evaluated for thickness, hardness, friability, drug content and in vitro dissolution rates. Formulation F6, having a hardness of 5.46 ± 0.25, showed the desired release profile for a period of 24 h in simulated intestinal fluids (pH 7.4). Kinetic data treatment indicated that the release of stavudine from the matrix tablet follows coupling of diffusion and erosion mechanisms. The study proves that the optimized sustained release tablet is capable of releasing the drug in a sustained manner for 24 h.
机译:本研究的目的是评估羧甲基罗望子酮粉末作为一种新型的药物释放阻滞剂。为了评估其相同性,通过使用直接压片技术,通过使用HPMC K4M和羧甲基罗望子酮内核粉制备司他夫定的缓释基质片剂。通过将不同的药物:聚合物比率配制成诸如F1至F9的制剂来制备制剂。评价压制片剂的厚度,硬度,脆性,药物含量和体外溶出速率。硬度为5.46±0.25的配方F6在模拟肠液(pH 7.4)中显示了24小时的所需释放曲线。动力学数据处理表明,司他夫定从基质片剂的释放遵循扩散和侵蚀机理的耦合。研究证明,优化的缓释片剂能够以24小时的持续方式释放药物。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号